The estrogen receptor-α agonist 16α-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Cardiac mass increases with age and with declining estradiol serum levels in postmenopausal women. Although the non-selective estrogen receptor-alpha and -beta agonist 17beta-estradiol attenuates cardiac hypertrophy in animal models and in observational studies, it remains unknown whether activation of a specific estrogen receptor subtype (ERalpha or ERbeta) might give similar or divergent results. Therefore, we analyzed myocardial hypertrophy as well as cardiac function and gene expression in ovariectomized, spontaneously hypertensive rats (SHR) treated with the subtype-selective ERalpha agonist 16alpha-LE2 or 17beta-estradiol. METHODS AND RESULTS: Long-term administration of 16alpha-LE2 or 17beta-estradiol did not affect elevated blood pressure, but both agonists efficiently attenuated cardiac hypertrophy and increased cardiac output, left ventricular stroke volume, papillary muscle strip contractility, and cardiac alpha-myosin heavy chain expression. The observed effects of E2 and 16alpha-LE2 were abrogated by the ER antagonist ZM-182780. Improved left ventricular function upon 16alpha-LE2 treatment was also observed in cardiac MRI studies. In contrast to estradiol and 16alpha-LE2, tamoxifen inhibited cardiac hypertrophy but failed to increase alpha-myosin heavy chain expression and cardiac output. CONCLUSIONS: These results support the hypothesis that activation of ERalpha favorably affects cardiac hypertrophy, myocardial contractility, and gene expression in ovariectomized SHR. Further studies are required to determine whether activation ERbeta mediates redundant or divergent effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Cited by
Iorga, A., Cunningham, C. M., Moazeni, S., Ruffenach, G., Umar, S., & Eghbali, M. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0152-8 · Cited by 914
“Treatment of spontaneously hypertensive OVX female rats with E2 or a selective ERα agonists resulted in improved endothelial function, reduced cardiac hypertrophy, and improved cardiac outcomes when compared to OVX rats without treatment [74, 75].”
BackgroundSex-Related Differences in Myocardial Remodeling
Piro, M., Della Bona, R., Abbate, A., Biasucci, L. M., & Crea, F. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.065 · Cited by 329
Estrogen Receptor-β: Recent Lessons from in Vivo Studies
Harris, H. A. (2007) · Molecular Endocrinology · doi:10.1210/me.2005-0459 · Cited by 280
Weigt, C., Hertrampf, T., Zoth, N., Fritzemeier, K. H., & Diel, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.013 · Cited by 56
“ER alpha mediated effects of E2 include uterus proliferation, inhibition of cardiac hyperthrophy, protection of bone mineral density, increased movement drive and body weight control (Hertrampf et al., 2007, 2008a,b; Hillisch et al., 2004; Pelzer et al., 2005).”
BackgroundSelf-citationHertrampf, T., Seibel, J., Laudenbach, U., Fritzemeier, K. H., & Diel, P. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707664 · Cited by 46
“The novel, highly selective steroidal ERb-specific agonist 8b-VE2 (BETA) and the highly selective ERa-specific agonist 16a-LE2 (ALPHA) (Hegele-Hartung et al., 2004; Hillisch et al., 2004; Pelzer et al., 2005) (Figure 1) belong to the most potent and isotype selective oestrogens identified so far.”
BackgroundSelf-citation
Metadata
- Authors
- PELZER, T., JAZBUTYTE, V, HU, K., SEGERER, S., NAHRENDORF, M., NORDBECK, P., BONZ, A., MUCK, J., FRITZEMEIER, K., & HEGELEHARTUNG, C.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 67
- Issue
- 4
- Pages
- 604-612
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2170775541
- Cited by
- 84
- References
- 2
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The estrogen receptor-α agonist 16α-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. https://app.cochat.ai/papers/10.1016/j.cardiores.2005.04.035
- The paper
- PELZER, T., JAZBUTYTE, V, HU, K., SEGERER, S., NAHRENDORF, M., NORDBECK, P., BONZ, A., MUCK, J., FRITZEMEIER, K., & HEGELEHARTUNG, C. (2005). The estrogen receptor-α agonist 16α-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovascular Research. https://doi.org/10.1016/j.cardiores.2005.04.035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.